INTERPLAY OF VON-WILLEBRAND-FACTOR (VWF) MUTATIONS ON GPIB-BINDING AND F-VIII-BINDING VARIANTS OF VON-WILLEBRAND DISEASE (VWD)

被引:0
作者
ROCK, AL
KRONER, PA
FAHS, S
KLUESSENDORF, M
FRIEDMAN, KD
MONTGOMERY, RR
机构
[1] BLOOD CTR SE WISCONSIN INC,BLOOD RES INST,MILWAUKEE,WI
[2] MED COLL WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53226
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A339 / A339
页数:1
相关论文
共 50 条
  • [41] The challenging management of a child with type 3 von Willebrand disease (VWD) and antibodies to von Willebrand factor (VWF)
    Platokouki, H.
    Pergantou, H.
    Xafaki, P.
    Adamtziki, E.
    HAEMOPHILIA, 2012, 18 : 44 - 44
  • [42] IDENTIFICATION OF A MOLECULAR DEFECT IN A PATIENT WITH VON-WILLEBRAND DISEASE AND DEFECTIVE BINDING OF FACTOR-VIII
    RICK, ME
    KRIZEK, DM
    BLOOD, 1994, 84 (10) : A59 - A59
  • [43] VON-WILLEBRAND DISEASE IN THE RIIIS/J MOUSE IS CAUSED BY A DEFECT OUTSIDE OF THE VON-WILLEBRAND-FACTOR GENE
    NICHOLS, WC
    COONEY, KA
    MOHLKE, KL
    BALLEW, JD
    YANG, A
    BRUCK, ME
    REDDINGTON, M
    NOVAK, EK
    SWANK, RT
    GINSBURG, D
    BLOOD, 1994, 83 (11) : 3225 - 3231
  • [44] IDENTIFICATION OF VON-WILLEBRAND-FACTOR (VWF) AMINO-ACID-RESIDUES CRITICAL FOR FACTOR-VIII (FVIII) BINDING
    CACHERIS, PM
    NICHOLS, WC
    GINSBURG, D
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 558 - 558
  • [45] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN DELAYS CLEARANCE OF VON-WILLEBRAND-FACTOR IN ACQUIRED VON-WILLEBRAND DISEASE
    VANGENDEREN, PJJ
    TERPSTRA, W
    MICHIELS, JJ
    KAPTEIJN, L
    VANVLIET, HHDM
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (05) : 891 - 892
  • [46] THE EFFECT OF ABO TYPE ON THE SYNTHESIS, RELEASE, AND PLATELET BINDING OF VON-WILLEBRAND-FACTOR (VWF)
    SCOTT, JP
    GILL, JC
    ROCK, A
    LEVINE, S
    VOKAC, EA
    MONTGOMERY, RR
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 946 - 946
  • [47] PROPHYLAXIS WITH FACTOR-VIII VON-WILLEBRAND-FACTOR CONCENTRATE AS SUPPORT OF HIGH-RISK PREGNANCY IN A WOMAN AFFECTED BY SEVERE VON-WILLEBRAND DISEASE
    CIAVARELLA, N
    SCHIAVONI, M
    ETTORRE, C
    FASANO, A
    STEFANILE, C
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1172 - 1172
  • [48] Clearance of von willebrand factor (VWF) in type 2 von willebrand disease (VWD): the implications of VWF propeptide (VWFPP) and VWF:Ag levels
    Haberichter, S. L.
    Castaman, G.
    James, P. D.
    Christopherson, P. A.
    Roheghiero, F.
    Lillicrap, D.
    Montgomery, R. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 10 - 10
  • [49] ACQUIRED VON-WILLEBRAND DISEASE-ASSOCIATED WITH MULTIPLE-MYELOMA - CHARACTERIZATION OF AN INHIBITOR TO VON-WILLEBRAND-FACTOR
    MOHRI, H
    TANABE, J
    OHTSUKA, M
    YOSHIDA, M
    MOTOMURA, S
    NISHIDA, S
    FUJIMURA, Y
    OKUBO, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) : 561 - 566
  • [50] Incorporation of von Willebrand Factor into a fibrin network induces activation of von Willebrand Factor enabling binding of GPIb
    Miszta, A.
    Pelkmans, L.
    Ruggeri, Z. M.
    Al Dieri, R.
    Du, V
    De Groot, P. H.
    Hermens, W.
    Hemker, C. H.
    Kelchtermans, H.
    De Laat, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 465 - 465